FORBES-TATE

Lobbying for ANTIMICROBIAL INNOVATION ALLIANCE · Development of antimicrobial resistance policy to assist life sciences industry.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · posted Oct 19, 2025

Lobbying activity 1

Health Issues

Issues related to the development of critical need antimicrobial biopharmaceuticals.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.